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Background: γ-lactamase is used for the resolution of γ-lactam which is utilized in the synthesizing of abacavir and
peramivir. In some cases, enzymatic method is the most utilized method because of its high efficiency and productivity.
The cellulose binding domain (CBD) of cellulose is often used as the bio-specific affinity matrix for enzyme immobilization.
Cellulose is cheap and it has excellent chemical and physical properties. Meanwhile, binding between cellulose and CBD
is tight and the desorption rarely happened.
Results: We prepared two fusion constructs of the γ-lactamase gene gla, which was from Sulfolobus solfataricus P2.
These two constructs had Cbd (cellulose binding domain from Clostridium thermocellum) fused at amino or carboxyl
terminus of the γ-lactamase. These two constructs were heterogeneously expressed in E. coli rosetta (DE3) as two fusion
proteins. Both of them were immobilized well on Avicel (microcrystalline cellulose matrix). The apparent kinetic
parameters revealed that carboxyl terminus fused protein (Gla-linker-Cbd) was a better catalyst. The Vmax and kcat
value of Avicel immobilized Gla-linker-Cbd were 381 U mg−1 and 4.7 × 105 s−1 respectively. And the values of the
free Gla-linker-Cbd were 151 U mg−1 and 1.8 × 105 s−1 respectively. These data indicated that the catalytic efficiency
of the enzyme was upgraded after immobilization. The immobilized Gla-linker-Cbd had a 10-degree temperature
optimum dropping from 80°C to 70°C but it was stable when incubated at 60°C for 48 h. It remained stable in catalyzing
20-batch reactions. After optimization, the immobilized enzyme concentration in transformation was set as 200 mg/mL.
We found out that there was inhibition that occurred to the immobilized enzyme when substrate concentration
exceeded 60 mM. Finally a 10 mL-volume transformation was conducted, in which 0.6 M substrate was hydrolyzed and
the resolution was completed within 9 h with a 99.5% ee value.
Conclusions: Cellulose is the most abundant and renewable material on the Earth. The absorption between Cbd
domain and cellulose is a bio-green process. The cellulose immobilized fusion Gla exhibited good catalytic characters,
therefore we think the cellulose immobilized Gla is a promising catalyst for the industrial preparation of (−) - γ-lactam.
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γ-lactamase (EC 3.5.2.-) is a small enzyme sub-classification
in amidase [1], which could be used for the resolution
of (rac)-2-azabicyclo [2.2.1] hept-5-en-3-one (γ-lactam)
[2]. The well-known utilizations of (−) γ-lactam are in
the synthesizing of abacavir [3] and peramivir [4]. These
two drugs were applied in the treatment for HIV, hepatitis
and influenza pandemic and have brought profits of* Correspondence: shengwu@im.ac.cn
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unless otherwise stated.several billions U.S dollars for the inventors and devel-
opers [5]. γ-Lactam could be applied in the syntheses of
other leading compounds and drugs too, such as MK-
0812 [6], piperidinium compound [7] and melogliptin
[8]. In the three preparation methods for the optically
pure enantiomers of γ-lactam [1,9-11], the enzymatic
method is the most often utilized method because of its
high efficiency and productivity. The method was first
reported by Taylor et al. [11]. In their work, microbial
whole cells were used in bio-enzymatic resolution of
racemic γ-lactam. Later, Littlechild and coworkers cloned
and purified a (−)-γ-lactamase from Aurobacterium sp.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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structure resolution [12]. Up to now four (+) -γ-lactamases
have been reported in the forms of E. coli recombinant pro-
teins [1,12-14], and others are used in forms of whole cells
[11,15,16].
In our previous research works, we immobilized a (+)
γ-lactamase (Gla) from Sulfolobus solfataricus fused with
a His-tags on nickel-chelating agarose and applied the
immobilized enzyme in batch reactions. However, agarose
is a fragile material and is much more expensive than
other immobilizing matrices such as resins. These disad-
vantages of the agarose-immobilized enzyme confined its
usage in scale application. Recently, the cellulose binding
domain (CBD) of cellulose is often used as the bio-specific
affinity matrix for enzyme immobilization. Compared with
agarose, cellulose is much cheaper, and it has excellent
chemical and physical properties. More importantly,
binding between cellulose and CBD is tight and the de-
sorption rarely happened [17]. Considering these merits
of the cellulose immobilized enzyme, we wonder a cbd-
fused-gla, immobilized to cellulose, represent a promising
catalyst for the resolution of racemic gamma lactam?
In this paper, we developed a method in which the CBD
fusion Gla was immobilized on the microcrystalline cellu-
lose matrix (Avicel). We found that the fusion enzyme
which had CBD fused at the C terminus was immobilized
well on the cellulose matrix, and the immobilized enzyme
was more stable than the free fusion enzyme in terms of
thermo-stability. The immobilized enzyme retained most
of its activity and had a relatively constant efficiency when
used for batch transformations. In addition, γ-lactamase
showed absolute enantioselectivity to (+)-γ-lactam. In con-
clusion, we believe that the fusion enzyme immobilized on
cellulose, reported in this paper, is a promising catalyst for
the industrial preparation of (−)- γ-lactam.
Methods
Bacterial strains, plasmids, and culture media
Escherichia coli DH5α (Transgen Biotech, Beijing, PRC)
cells were used for the cloning studies. E. coli rosetta
(DE3) (Novagen, Darmstadt, Germany) cells were used for
protein expression. pET30a (+) (Invitrogen, California,
USA) was used for standard cloning and expression in
E. coli. The E. coli strains were routinely grown in LB
medium or on LB agar plates at 37°C. To select bacterial
strains carrying the appropriate recombinant plasmids,
35 μg chloramphenicol mL−1 or 50 μg kanamycin mL−1
was added to the medium. S. solfataricus P2 genomic
DNA was obtained from the American Type Culture Col-
lection (ATCC, Manasas, VA; catalog number 35092).
Extraction and purification of DNA
Plasmids were isolated using the TIANprep Mini Kit
(Tiangen, Beijing, PR China) according to the protocolprovided by the manufacturer. DNA was purified using the
TIANgel Midi Kit (Tiangen, Beijing, PR China) according
to the manufacturer’s instructions.
Gene fusion of gla and cip
The cbd encoding gene encoding the partial Cbd domain
(from 2113 bp to 2581 bp of gene HF912724.1, [18]) was
amplified from genomic DNA of Clostridium thermo-
cellum ATCC 27405 (ATCC, Manasas, VA) using primer
p1 and p2 with NcoI and BamHI sites respectively (Table 1).
A linker sequence GSAGSA was introduced at the C
terminus of cbd. The PCR protocol consisted of an ini-
tial denaturation step of 5 min at 95°C, followed by
30 cycles of 1 min at 95°C, 1 min at 53°C, 1 min at 72°C
and ending with a final elongation step for 10 min at 72°C.
PCR was performed with Red-Pfu DNA Polymerase (Bio-
colors, Beijing, China). The PCR product was inserted into
the according sites of pET30a and the plasmid was named
as pETcbd.
The gene encoding the γ-lactamase Gla (GenBank ac-
cession no AF290611) was amplified from genomic
DNA of Sulfolobus solfataricus P2 using primer p3 and
p4 with BamHI and XhoI sites respectively. (Table 1).
The PCR protocol was same as for cbd. The PCR prod-
uct was inserted into the BamHI and XhoI sites of
pETcbd and the final plasmid was named as pETcbdgla.
This plasmid harbored a cbd-linker-gla fusion gene.
In a same way, gla was amplified with primer p5 and
primer p6 and inserted into the NdeI and BamHI sites
of pET30a (pETgla). The linker sequence was introduced
at the C terminal of gla. Then cbd was amplified with
primer p7 and p8 and introduced into downstream the
linker sequence (BamHI and XhoI sites). The final plasmid
was named as pETglacbd and it harbored a gla-linker-cbd
fusion gene.
Expression of fusion gene in E. coli rosetta (DE3) cells
E. coli rosetta (DE3) was chosen as the expression strain
because in the strain Gla showed higher specific activity
than in other strains such as E. coli (DE3) (data not
shown). This is because there were many rare codons
existed in gla gene. The constructs were transformed into
E. coli rosetta (DE3) cells and has grown overnight at 37°C.
Stock culture (5 mL) was transferred into fresh 500-mL
culture medium and has grown up to an optical density
of 0.8 (OD 580). Isopropylthiogalactoside (IPTG) was
then added to a final concentration of 1.0 mM, and after
incubation for 2 h, the cells were harvested by centrifu-
gation (4,000 × g for 10 min).
Purification of Gla fusion proteins on a nickel (Ni)-chelating
column
Purification of the γ-lactamase fusion protein on the
Ni-chelating column was carried out using the protocol
Table 1 Primers used in this study
Name Sequence (5′→ 3′)a Description
p1 forward CGCCATGGATTTGAAGGTTGAATTCTAC For construction of pETcbd
p2 reverse CGGGATCCAGCGGAGCCAGCGGAGCC CACCGGGTTCTTTACCC
p3 forward GCGGATCCATGGGAATTAAGTTACCCACATTG For construction of pETcbdgla
p4 reverse CGCTCGAGTTTTTTGATTCTCTCAAATACAT
p5 forward CGCATATGGGAATTAAGTTACCCACATTG For construction of pETgla
p6 reverse GCGGATCCAGCGGAGCCAGCGGAGCCTTTTTTGATTCTCTCAAATACAT
p7 forward GCGGATCCAATTTGAAGGTTGAATTCTACAAC For construction of pETglacbd
p8 forward CGCTCGAG CACCGGGTTCTTTACCC
aRestriction sites are underlined, sequence encoding the linker peptide were in italics and in grey shade.
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Cells from the expression culture (500 mL) were sus-
pended in 40 mL binding buffer (50 mM Tris–HCl,
300 mM NaCl, and 10 mM imidazole, pH 8.0) and
disrupted by ultrasonication. The crude samples were
heated to 60°C for 10 min then centrifuged. The super-
natant was applied to a 1-mL Novagen His•Band gravity
flow column that had been equilibrated with 20 mL
Ni-NTA binding buffer. The column was then washed
with 20 mL wash buffer (50 mM Tris–HCl, 300 mM
NaCl, and 20 mM imidazole, pH 8.0). The His-tagged
proteins were eluted with 10 mL elution buffer (50 mM
Tris–HCl, 300 mM NaCl, and 200 mM imidazole, pH 8.0).
To remove the imidazole present in the elution buffer,
the eluate was applied to a 5-mL HiTrap desalting col-
umn (GE Healthcare, New Jersey, USA) connected to an
ÄKTA FPLC system (GE Healthcare), and the column was
eluted with 50 mM Tris–HCl buffer (pH 7.5, 150 mM
NaCl). The protein samples were collected and dialyzed
against 5000 mL of 50 mM Tris–HCl buffer (pH 8.0). The
buffer was changed three times over a period of 24 h. The
samples were then ready for use.Immobilization of the crude or purified γ-lactamase fusion
proteins on Avicel
For crude fusion proteins, cells from the expression cul-
ture (500 mL) were suspended in 40 mL ultrasonication
buffer (50 mM Tris–HCl, pH 8.0) and disrupted by ultra-
sonication. The ultrasonication sample was heated to 60°C
for 10 min then centrifuged (13,000 × g, 10 min). 5 mL of
supernatant was added with 1 g of Avicel and kept at 25°C
for 120 min with stirring. For purified fusion proteins,
1 mL protein solutions (20 mg protein in 50 mM Tris–
HCl, pH 8.0) were added with 100 mg Avicel and kept at
25°C for 120 min with stirring. Finally the immobilized
fusion proteins were collected by centrifuge (3,000 × g,
10 min). From hereafter the mass of the immobilized
enzyme was included in Avicel and the mass of the
absorbed protein on Avicel. When protein concentrationof immobilized enzyme was involved in calculations, only
the mass of the absorbed protein was counted.
Adsorption Isotherm Measurements for crude fusion
proteins
Adsorption isotherm measurements were conducted at
room temperature (25°C) in 50 mL tubes. Samples contain-
ing 2,000 mg of crude fusion proteins (supernatant samples
after treated at 60°C, total activity 5500 U) and 1 g of Avicel
were mixed in a final aqueous volume of 5 mL. Suspensions
were incubated for 120 min to allow the adsorption to sat-
urate. The protein concentration of the supernatant was
measured at regular intervals using a BCA protein assay kit
(Pierce, USA), and this value was then subtracted from the
initial amount of protein and the difference was considered
to be amount of proteins adsorbed onto Avicel. Otherwise,
the total activity of supernatant was measured and this
value was then subtracted from the initial enzyme activity.
All values were measured in triplicate.
Standard reaction conditions and γ-lactamase activity
assay
γ-Lactamase activity was assayed by adding 1 mg of
enzyme (or 25 mg immobilized enzyme) to 200 μL of the
4.6 mM substrate solution (pH 7.0, 50 mM phosphate buf-
fer). If not specified, the reaction solution was incubated
at 70°C for 30 min. After transformation the reaction
solution was extracted with 100 μL ethyl acetate and
analyzed by chiral HPLC. One unit (U) of enzyme activ-
ity was defined as the amount of enzyme that catalyzed
the conversion of one micromole of substrate per mi-
nute. As to immobilized enzyme the absorbed protein
was first calculated based on the binding capacity de-
scribed above, then the activity was determined.
Temperature optimum and temperature stability
determination
For temperatue optimum determination, the transform-
ation solutions (free enzyme) or suspensions (immobilized
enzyme) as described in standard reaction conditions were
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to 90°C with a 10 degree interval. Then the samples were
analyzed as described in standard reaction conditions and
activity assay.
For temperature stability determination, 50 μL of enzyme
solution (1 mg enzyme in pH 7.0, 50 mM phosphate buffer)
or 100 μL of immobilized enzyme suspension (25 mg
immobilized enzyme, pH 7.0, 50 mM phosphate buffer)
were incubated at various temperature from 20°C to 90°C
with a 10 degree interval for 30 min. Then the enzyme so-
lution or suspension was added to the substrate solution as
described in standard reaction conditions. The samples
were allowed to react and later analyzed as described in
standard reaction conditions and activity assay.
Analytical chiral HPLC
The reaction solution (200 μL) was extracted with 100 μL
ethyl acetate, and benzamide was added to the extract as
the internal standard. The ethyl acetate extract (10 μL)
was applied to a Daicel Chiralpak AS-H column (Daicel,
Tokyo, Japan) and eluted with a mobile phase consisting
of 80% acetonitrile and 20% isopropanol (volume ratio).
The UV absorbance of eluted γ-lactam was measured at
230 nm. Benzamide, (+) γ-lactam, and (−) γ-lactam had
retention times of 8.7, 11.8, and 13.9 min, respectively, at a
flow rate of 0.6 mL/min.
Determination of the apparent kinetic parameters
The apparent kinetic parameters were determined by the
Lineweaver-Burk plot. Enzymatic reactions were carried
out with substrate solutions of different concentrations
(ranging from 4.6 mM to 32.2 mM). To ensure accuracy,
substrate conversion was controlled below 10%.Figure 1 Construction of cbd-linker-gla and gla-linker-cbd fusion gene
isotherm measurements for crude fusion proteins (C). A. his6: his-tag e
on pET30; B. 1.E. coli rosetta (DE3) harboring pET30; 2.E. coli rosetta (DE3) ha
Cbd-Linker-Gla; 5.Purified Gla-Linker-Cbd C. The total activity of Gla-Linker-CProtein assay and sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE)
The protein concentration was determined by the BCA
Protein Assay Kit from Pierce (Rockford, USA) using bo-
vine serum albumin (BSA) as the standard. SDS-PAGE
was performed as described earlier using a 6% stacking
gel and 12% separating gel [19].
DNA sequencing
DNA sequencing reactions were performed on a plas-
mid template using the ABI Prism BigDye terminator
cycle sequencing ready reaction kits (Applied Biosys-
tems, California, USA) and an ABI PRISM 377 DNA
sequencer (Applied Biosystems).
Software and online service
The BLAST × [20] program was used for protein hom-
ology search.
Results and discussion
Expression and purification of γ-lactamase fusion proteins
The γ-lactamase structural gene was a 1,515-bp frag-
ment. The cbd encoding gene was a 469-bp fragment
[18] and the linker sequence was an 18-bp fragment.
The two fusion gene constructs were expressed as two
separate proteins respectively. The cbd-linker-gla con-
struct expressed a 78-kDa fusion enzyme that had a
4.7-kDa fusion peptide at its amino (N) terminus and a
His-tag at its carboxyl (C) terminus (pET30a). The
other construct (gla -linker-cbd) expressed a 74.2-kDa
single fusion enzyme that only had a 0.9-kDa C ter-
minal His-tag (Figure 1A). The recombinant enzymes
were expressed in the soluble fraction of the bacterials (A) and expression of the two constructs (B) and adsorption
ncoding gene; thr and s tag: thrombin cleavage site and S peptide tag
rboring pETcbdgla; 3.E. coli rosetta (DE3) harboring pETglacbd; 4.Purified
bd supernatant at 0 h (5500 U) was set as 100% relative activity.
Table 2 Apparent kinetic parameters of the free fusion
proteins and their immobilized counterparts
Fusion protein Km (mmol l
−1) Vmax (U mg
−1) kcat (s
−1)
Cbd-Linker-Gla 14.3 ± 1.6 71.6 ± 4.2 8.8 × 104
Immobilized
Cbd-Linker-Gla
34.0 ± 1.6 344.9 ± 31.2 4.2 × 105
Gla -Linker- Cbd 5.7 ± 0.1 151.5 ± 30.3 1.8 × 105
Immobilized
Gla -Linker- Cbd
25.0 ± 1.6 381.6 ± 44.2 4.7 × 105
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cation on Ni-chelating column, the purified proteins
were applied for SDS-PAGE (Figure 1B lane 4 and 5).
There was a low-molecular-weight protein contamin-
ation in the pure protein of gla -linker-cbd, therefore
in this paper the enzyme activity of gla -linker-cbd was
probably lower than the actual value.
Comparison of the apparent kinetic parameters
Analysis of the apparent kinetic parameters revealed obvi-
ous differences in the Km,Vmax and kcat values of the two
forms of free fusion γ-lactamase protein. The changes in
these values indicated that the N-terminal Cbd fusion en-
zyme showed lower substrate affinity than the C-terminal
Cbd fusion enzyme, and its Vmax and kcat values were alsoFigure 2 Comparison of the optimal temperatures (A) and thermosta
counterpart, and thermostability of immobilized Gla-Linker-Cbd at 60°C
Thermostability. The activity of immobilized Gla-Linker-Cbd at 70°C (A) or
100% relative activity. In B, firstly enzymes were incubated at designated t
immobilized Gla-Linker-Cbd in cubated at 60°C (C) or the first batch (D, 11much lower than the C-terminal fusion enzyme (Table 2).
After immobilization the Km and Vmax values of both
fusion proteins were improved, and their kcat values
were also upgrade significantly. However, there was no
obvious difference on enzyme turnover number between
the C-terminal Cbd fused enzyme and the N-terminal
Cbd fused enzyme.
Adsorption isotherm measurements for crude fusion
proteins and purified Gla-Linker-Cbd
To make the method more feasible, first we tried to ab-
sorb the crude fusion proteins (supernatants after
ultrasonication) on Avicel. The adsorption isotherms of
the two crude fusion proteins were measured. However,
the protein concentration changes were too small and
the experiment errors were far beyond normal values.
Therefore, the relative activities of the crude protein
supernatants instead of the protein concentration were
determined. After absorption the remaining super-
natants and the enzyme absorbed Avicels were applied
for (rac)-γ-lactam transformation at 60°C and then the
transformations were analyzed by chiral HPLC respect-
ively. The total activities of the supernatant and immobi-
lized enzyme were calculated. According to Figure 1C, the
binding between Gla-Linker-Cbdand Avicel was faster
than the binding between Cbd-Linker-Gla and Avicel.bilities (B) between free Gla-Linker-Cbd protein and its immobilized
and 70°C (C) and batch stability (D). A. Optimal temperature; B.
firstly incubated at 30°C for 30 min (B, 145 ± 12 U mg−1) was set as
emperature for 30 min then applied for catalysis. The activity of
6 ± 6 U mg−1) was set as 100% relative activity.
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The purified fusion proteins were also used in the absorp-
tion experiments. Both the adsorption ratios of the two
purified proteins on Avicel were 40 ± 6 mg protein per g
Avicel. The binding capacity was calculated to be 0.8 ±
0.1 μM/g, which was in the range for CBD-fusion proteins
[21-23]. The binding saturation time of the purified protein
was same as the crude protein (data not shown). Based on
the above experiment result, Gla-Linker-Cbd immobilized
protein was chose for further experiments.
Comparison of the temperature property of free
Gla-Linker-Cbd protein and its immobilized counterpart
The temperature optima and thermostability of Gla-Linker-
Cbd and its immobilized counterpart were determined.
The optimal temperature of Gla protein was at 80°C [2].
However, after fused with Cbd the optimal temperatures of
the fusion protein and its immobilized counterpart dropped
from 80°C to 70°C (Figure 2A). The immobilized enzyme
exhibited higher specific activity than the free enzyme.
Meanwhile, according to Figure 2B, after incubated at 80°C
for 30 min, the fusion protein lost almost 80% of its original
activities while its immobilized counterpart only lost 30% of
its original activities.
Protein thermostability was often related to protein
rigidity [24]. In C. thermocellum most of the Cbd fusionFigure 3 Optimal concentration of immobilized enzyme (A) and subs
chiral HPLC analyses of the (rac)-γ-lactam control (D) and sample afte
Gla-Linker-Cbd at 60°C (A, 120.6 ± 5.2 μmol/min) and immobilized Gla-Linke
relative activity. The line in dot in B represents no substrate inhibition to
concentration 200 mg/ml, transformation temperature 60°C.enzymes showed maximum activity at 65°C or 75°C, and
had weak thermostabilities at 80°C [25-27]. Therefore, com-
pared to Gla the rigidity of the fusion protein probably was
reduced. In this balance process Cbd was the determinant
part to affect the protein thermostability.
Stability of immobilized enzymes at 60°C and 70°C
All the other conditions were same as described in
standard transformation conditions. The thermosta-
bility of the immobilized enzyme was tested at 60°C
and 70°C respectively. The immobilized enzyme was
stable at 60°C even incubated for 48 h. However, when
incubated at 70°C for 1 h the enzyme lost their 20% of
the initial activity. If the incubation time extended to
48 h, the immobilized enzyme lost their 40% initial
activity (Figure 2C). The batch stability was tested at 60°C
for 20 batches reactions. After each transformation, the
immobilized enzyme was collected by centrifuge and ap-
plied for another transformation. According to Figure 2D,
the immobilized enzyme maintained almost 100% of their
initial activity after 20 batches reactions.
Optimization of the concentrations of immobilized
enzymes and substrate in batch transformation
In term of cost saving, in a transformation the substrate
concentration should be as high as possible, and thetrate (B), and time course of the optimized transformation (C) and
r the 9 h transformation (E). The activity of 200 mg/ml immobilized
r-Cbd to 60 mM substrate (B, 338.6 ± 15.2 μmol/min) was set as 100%
enzyme. C: Substrate concentration 0.6 M, immobilized enzyme
Wang et al. BMC Biotechnology 2014, 14:40 Page 7 of 8
http://www.biomedcentral.com/1472-6750/14/40transformation time should be as short as possible. Taking
into account of these two factors, we tested first the high-
est immobilized enzyme concentration employed in the
system, and then the highest substrate concentration. In
these optimizations, the initial velocity of transformation
was used as the response factor. According to Figure 3A,
the optimal enzyme amount in the transformation system
was 200 mg/mL. Beyond or below this value, the initial
velocity of reaction dropped dramatically. It was easy to
understand that lower enzyme amount meant lower cata-
lytic activity. On the other hand, 200 mg immobilized en-
zyme almost had an autogenous volume of 0.5 mL in
transformation buffer, and it was impossible to stir the re-
action suspension sufficiently in the situation. Therefore
the mass transfer efficiency of the system was probably af-
fected severely [28] and the initial velocity of the enzyme
was reduced significantly.
The enzyme initial velocity would be upgraded by in-
creasing the substrate amount till it reached and main-
tained maximum activity if there was no substrate
inhibition [29]. According to Figure 3B, when the sub-
strate concentration exceeded 60 mM, the initial velocity
of the enzyme dropped obviously, which indicated that
substrate inhibition occurred.
Though there is substrate inhibition, it does not mean
that higher concentration can’t be applied. We tested the
maximum substrate concentration for 200 mg/mL im-
mobilized enzyme in prolonged reaction time. When the
substrate concentration was below 0.6 M, the reaction
conversion reached 49.8% in various time. If the substrate
concentration was beyond this value, the conversion
hardly reached 40% even transformed for 96 h, which was
very uneconomical (data not shown).
After optimization, we conducted a 10 mL-volume trans-
formation in which 2 g immobilized enzyme was suspended
in 0.6 M substrate buffer solution. The reaction was con-
ducted at 60°C and at a certain time interval, 10 μL of sam-
ple aliquot was extracted with ethyl-acetate and then
applied for chiral HPLC analysis. According to Figure 3C,
the transformation was completed within 9 h (49.5% con-
version). The ee value of the remaining substrate (−) γ-
lactam was 99.5% (Figure 3E). The reaction solution was
extracted with 30 mL dichloromethane each time for
three times. The combined solvent was recovered by
using rotary evaporator. At last, 0.30 g (−) γ-lactam in
crystal was recovered from the transformation solution,
and the recovery rate was 92%.
Conclusions
In our previous work, we employed a single purification
and immobilization method to immobilize Sulfolobus
solfataricus γ-lactamase on Ni-NTA agarose. The method
is simple and easy to conduct. And as we reported previ-
ously [2] Vmax and kcat value of the agarose immobilizedenzyme were around 450 U mg−1 and 4.2 × 105 s−1 re-
spectively, which indicated it was also an efficient immobi-
lized catalyst same as the cellulose immobilized enzyme.
However because of the fragility of agarose, the activity of
immobilized enzyme decreased sharply after multiple us-
ages probably due to the structure crash of agarose. It was
clear that the decrease did not come from protein inacti-
vation, because under the same condition the enzyme was
not deactivated even for a longer time. On the contrary
cellulose is a strong material. Therefore it is a very good
candidate as immobilizing material also because it is the
most abundant and renewable material on the Earth.
And most importantly, unlike glutaraldehyde cross-
linked immobilization, the absorption between Cbd do-
main and cellulose is a bio-green process, in which no extra
energy or expensive and harming catalyst is needed. Based
on the data provided in this paper we think the cellulose
immobilized Gla is a promising catalyst for the industrial
preparation of (−)-γ-lactam, which is a very important drug
intermediate.
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